Orange Grove Bio

Orange Grove Bio is a biotechnology holding and investment company dedicated to accelerating the development of innovative, patient-centric therapies for cancer, autoimmune, and inflammatory diseases. Founded in 2019 and headquartered in Cincinnati, Ohio, the company bridges the gap between promising early-stage research programs and successful commercialization of transformative therapies. Orange Grove Bio partners with research institutions across the Midwest, Southeast, and Mid-Atlantic regions — areas traditionally underserved by venture capital — to ensure groundbreaking discoveries reach the patients who need them. The company closed a new financing round led by Denver-based investors in 2024.